Job Watch

Notice of Special Interest (NOSI):Sleep and Substance Use Disorders

Notice NOT-DA-20-021 from the NIH Guide for Grants and Contracts

AstraZeneca : Postdoc Programme

New Scientist - Bioinformatics - Wed, 2020-03-25 11:47
Competitive + Benefits: AstraZeneca : In our global biologics research and development arm, our mission is centred on delivering life-changing products.. Gaithersburg, MD, Waltham, MA in the US, Cambridge or Macclesfield in the UK or Gothenburg, SE
Categories: Job Watch

Revolutionizing Innovative, Visionary Environmental Health Research (RIVER) (R35 Clinical Trial Optional)

Funding Opportunity RFA-ES-20-009 from the NIH Guide for Grants and Contracts. The NIEHS Revolutionizing Innovative, Visionary Environmental health Research (RIVER) program is intended to provide support for outstanding investigators in the Environmental Health Sciences, giving them intellectual and administrative freedom, as well as sustained support to pursue their research in novel directions in order to achieve greater impacts. The program seeks to identify individuals, regardless of career stage, with a potential for continued innovative and impactful research and combine their existing investigator-initiated research into a single award to support the majority of their independent environmental health sciences research program.

Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R21- Clinical Trial Not Allowed)

Funding Opportunity PAR-20-148 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to encourage research investigating the roles of extracellular RNA (exRNA) carrier subclasses in biological processes relevant to substance use disorders (SUDs) and/or HIV infection, latency, or pathogenesis in the CNS. Applicants may propose to investigate biological mechanisms involving exRNA carrier subclasses, or propose to develop improved technologies to investigate extracellular vesicles or other exRNA carriers.

Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R01- Clinical Trial Not Allowed)

Funding Opportunity PAR-20-147 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to encourage research investigating the roles of extracellular RNA (exRNA) carrier subclasses in biological processes relevant to substance use disorders (SUDs) and/or HIV infection, latency, or pathogenesis in the CNS. Applicants may propose to investigate biological mechanisms involving exRNA carrier subclasses, or propose to develop improved technologies to investigate extracellular vesicles or other exRNA carriers.

Pages

Subscribe to Anil Jegga aggregator - Job Watch